Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Non-Current Assets (2017 - 2025)

Cue Biopharma (CUE) has disclosed Other Non-Current Assets for 9 consecutive years, with $94000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 10.48% to $94000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94000.0 through Dec 2025, down 10.48% year-over-year, with the annual reading at $94000.0 for FY2025, 10.48% down from the prior year.
  • Other Non-Current Assets hit $94000.0 in Q4 2025 for Cue Biopharma, down from $153000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $3.0 million in Q1 2023 to a low of $94000.0 in Q4 2025.
  • Historically, Other Non-Current Assets has averaged $674800.0 across 5 years, with a median of $150500.0 in 2021.
  • Biggest five-year swings in Other Non-Current Assets: surged 2121.64% in 2023 and later tumbled 94.93% in 2024.
  • Year by year, Other Non-Current Assets stood at $150000.0 in 2021, then changed by 0.0% to $150000.0 in 2022, then fell by 22.0% to $117000.0 in 2023, then fell by 10.26% to $105000.0 in 2024, then decreased by 10.48% to $94000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for CUE at $94000.0 in Q4 2025, $153000.0 in Q3 2025, and $153000.0 in Q2 2025.